Deltagen (Deltagen) Change In Receivables : $1.68 Mil (TTM As of Jun. 2007)

View and export this data going back to 2000. Start your Free Trial

What is Deltagen Change In Receivables?

Deltagen's change in receivables for the quarter that ended in Jun. 2007 was $-0.31 Mil. It means Deltagen's Accounts Receivable increased by $0.31 Mil from Mar. 2007 to Jun. 2007 .

Deltagen's change in receivables for the fiscal year that ended in Dec. 2006 was $0.83 Mil. It means Deltagen's Accounts Receivable declined by $0.83 Mil from Dec. 2005 to Dec. 2006 .

Deltagen's Accounts Receivable for the quarter that ended in Jun. 2007 was $1.71 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Deltagen's Days Sales Outstanding for the three months ended in Jun. 2007 was 253.34.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Deltagen's liquidation value for the three months ended in Jun. 2007 was $3.47 Mil.

Deltagen Change In Receivables Historical Data

The historical data trend for Deltagen's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltagen Change In Receivables Chart

Deltagen Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec05

Dec06

Change In Receivables

Get a 7-Day Free Trial

-1.10

-0.91

-3.01

0.83

Deltagen Quarterly Data
	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07
Change In Receivables	Get a 7-Day Free Trial															-2.85	1.57	0.15	0.27	-0.31

Deltagen Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.68 Mil.

Deltagen (OTCPK:DGEN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Deltagen's Days Sales Outstanding for the quarter that ended in Jun. 2007 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.713	/	0.617	*	91
=	253.34

2. In Ben Graham's calculation of liquidation value, Deltagen's accounts receivable are only considered to be worth 75% of book value:

Deltagen's liquidation value for the quarter that ended in Jun. 2007 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2.674	-	0.49	+	0.75 * 1.713	+	0.5 * 0
=	3.47

Deltagen Change In Receivables Related Terms

Thank you for viewing the detailed overview of Deltagen's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Deltagen (Deltagen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltagen Inc (OTCPK:DGEN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 S. Norfolk Street, Suite 105, San Mateo, CA, USA, 94403

Website

http://www.deltagen.com

Deltagen Inc is a provider of drug discovery tools and services to the biopharmaceutical industry.

Deltagen (Deltagen) Headlines

No Headlines